Aurobindo Pharma Q2 net up at 33% at Rs 605 cr

G Naga Sridhar Hyderabad | Updated on January 15, 2018

Aurobindo Pharma Ltd’s consolidated net profit increased 33 per cent at Rs 605.64 crore in the second quarter ended September 30, 2016 compared to Rs 453.55 crore in the corresponding quarter of previous financial year.

The total revenue of the Hyderabad-based company has increased 12% at Rs 3775 cr as against Rs 3365 crore.

The board of the company has approved an interim divided of 125 per cent per equity share of Rs 1 for the year 2016-17.

Published on November 14, 2016

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

This article is closed for comments.
Please Email the Editor

You May Also Like